<DOC>
	<DOCNO>NCT00594529</DOCNO>
	<brief_summary>The purpose study evaluate safety liver resection metastatic , resectable lesion colorectal cancer systemic chemotherapy .</brief_summary>
	<brief_title>Feasibility Study Neoadjuvant Chemotherapy Modified FOLFOX6 Resectable Liver Metastases Colorectal Cancers</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>1 . Histologically diagnosed colorectal adenocarcinoma , include cecal , appendiceal , anal canal cancer . 2 . Liver lesion measurable spiral CT SPIOMRI scan . 3 . Extrahepatic lesion include lung metastasis resect curatively . 4 . Curative resection metastatic lesion perform residual hepatic function preserve . 5 . No prior treatment history liver lesion , include LOHP regimen , hepatectomy , hepatic arterial infusion , MCT , RFA 6 . No evidence chronic hepatic disease affect systemic chemotherapy and/or surgical resection 7 . Performance status ( ECOG ) : 01 8 . Vital organ function , include hematopoietic , cardiac , respiratory renal function , preserve . Excluded case condition : 1 . Peritoneal pleural fluid retention drain . 2 . Multiple malignancy treat . 3 . Peripheral neural disturbance . 4 . Active infectious disease . 5 . Severe watery diarrhea . 6 . Mental disturbance . 7 . Treatment history continuous , oral intravenous steroid therapy . 8 . Previous history ischemic heart disease . 9 . Coexistent severe diseases include pulmonary fibrosis , interstitial pneumonia , ileus , uncontrollable diabetes , cardiac dysfunction , hepatic failure , renal failure . 10 . Pregnant . 11 . Previous history severe druginduced allergy .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Neoadjuvant chemotherapy</keyword>
	<keyword>Metastatic liver lesion colorectal cancer</keyword>
</DOC>